NK
Naresh Kumar Anand
About Naresh Kumar Anand
Data last updated:
Naresh Kumar Anand is a Director at Jeewan Anand Healthcare Private Limited (since 2022), Director at Sarv Hiteshi Pharma Private Limited (since 2021) and Director at Schelling Pharma Private Limited (since 2019). The companies operate in Healthcare, Home Appliances and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹10.64 Cr; the largest is Jeewan Anand Healthcare Private Limited at ₹5.45 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jeewan Anand Healthcare Private Limited U85110RJ2021PTC074638 | Director | 21 Aug 2022 | 2021 | ₹5.45 Cr (FY 2024) | Active |
| Sarv Hiteshi Pharma Private Limited U52339RJ2021PTC074795 | Director | 30 Apr 2021 | 2021 | ₹4.97 Cr (FY 2024) | Active |
| Schelling Pharma Private Limited U51909RJ2019PTC064320 | Director | 19 Mar 2019 | 2019 | ₹21.7 Lakh (FY 2023) | Active |
Board colleagues of Naresh Kumar Anand
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepak Anand | 09151488 | Jeewan Anand Healthcare Private Limited , Sarv Hiteshi Pharma Private Limited | Director |
| Neha Hans | 09151489 | Jeewan Anand Healthcare Private Limited | Director |
| Suman Lata Chopra | 09162081 | Sarv Hiteshi Pharma Private Limited | Director |
| Hem Lata Phoolia | 08394362 | Schelling Pharma Private Limited | Director |
| Ved Prakash Ahuja | 08394383 | Schelling Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naresh Kumar Anand
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naresh Kumar Anand
Naresh Kumar Anand currently holds 3 directorships: Jeewan Anand Healthcare Private Limited (Director, since 21 Aug 2022, revenue ₹5.45 Cr (FY 2024)); Sarv Hiteshi Pharma Private Limited (Director, since 30 Apr 2021, revenue ₹4.97 Cr (FY 2024)); Schelling Pharma Private Limited (Director, since 19 Mar 2019, revenue ₹21.7 Lakh (FY 2023)).
Naresh Kumar Anand was first appointed on 19 Mar 2019 as Director at Schelling Pharma Private Limited. The most recent appointment on record is 21 Aug 2022 at Jeewan Anand Healthcare Private Limited.
The 3 current companies of Naresh Kumar Anand that report revenue have a combined latest revenue of ₹10.64 Cr: Jeewan Anand Healthcare Private Limited ₹5.45 Cr (FY 2024); Sarv Hiteshi Pharma Private Limited ₹4.97 Cr (FY 2024); Schelling Pharma Private Limited ₹21.7 Lakh (FY 2023).
The current boards of Naresh Kumar Anand's companies include Deepak Anand (Jeewan Anand Healthcare Private Limited), Neha Hans (Jeewan Anand Healthcare Private Limited), Suman Lata Chopra (Sarv Hiteshi Pharma Private Limited), Hem Lata Phoolia (Schelling Pharma Private Limited), Ved Prakash Ahuja (Schelling Pharma Private Limited).